Alterations of immune functions in heroin addicts and heroin withdrawal subjects.
Conflicting results, both decreased and increased, have been reported concerning the function of T-lymphocytes in heroin addicts. We investigated the alterations of T-lymphocyte proliferative responses and immunophenotypic markers on lymphoid cells in heroin addicts and during different periods of heroin withdrawal in addicted subjects. This study has demonstrated a decrease in the response of T-lymphocytes to 1.2, 2.5, 5 and 10 microg/ml of phytohemagglutinin stimuli in heroin addicts and 1- to 5-day heroin withdrawal subjects compared with controls. Similarly, in an in vitro study, 10(-4), 10(-6) and 10(-8) M concentrations of morphine were shown to suppress 0.6 and 2.5 microg/ml of PHA-stimulated T-lymphocyte obtained from naive subjects. This inhibitory effect of morphine on PHA stimulation was completely abolished by 100 microM naloxone. The immunological parameters of total T-lymphocytes (CD3), T-helper cells (CD4), cytotoxic T-cells (CD8), B-cells and natural killer cells that are the immunophenotypic markers studied by flow cytometric analysis were altered in heroin addicts, 15- to 21-day and 6- to 24-month heroin withdrawal subjects, when compared with controls. These results suggest that heroin addicts and short period (15 to 21 days and 6 to 24 months) of heroin withdrawal have decreases in their immune system functioning and that the heroin withdrawal subjects seem to gradually reverse their immunological parameters to normal levels when withdrawal was sustained >/=2 years. This is the first report examining immune function in heroin withdrawal subjects using the "cold turkey" method. The results are beneficial for further study of the mechanism responsible for the opioid-induced changes in immune function.
Govitrapong
P
P
Neuro-Behavioural Biology Center, Institute of Science and Technology for Research and Development, Mahidol University at Salaya, Nakornpathom 73170, Thailand. grpkk@mahidol.ac.th
Suttitum
T
T
Kotchabhakdi
N
N
Uneklabh
T
T
D000328:Adult; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D005260:Female; D005434:Flow Cytometry; D019085:Fluorescent Antibody Technique, Direct; D003932:Heroin / Q000009:adverse effects*; D006556:Heroin Dependence / Q000276:immunology*; D006801:Humans; D018655:Lymphocyte Count / Q000187:drug effects; D008297:Male; D009294:Narcotics / Q000009:adverse effects*; D010835:Phytohemagglutinins; D013375:Substance Withdrawal Syndrome / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013997:Time Factors
D009294:Narcotics; D010835:Phytohemagglutinins; D003932:Heroin